Displaying 151 - 180 of 180CSV
Obradovic, A., Graves, D., Korrer, M., Wang, Y., Roy, S., Naveed, A., Xu, Y., Luginbuhl, A., Curry, J., Gibson, M., Idrees, K., Hurley, P., Jiang, P., Liu, X. S., Uppaluri, R., Drake, C. G., Califano, A., & Kim, Y. J. (2022). Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer. Clinical Cancer Research, 28(10), 2094–2109. https://doi.org/10.1158/1078-0432.ccr-21-3570
Publication Date
Cambuli, F., Foletto, V., Alaimo, A., De Felice, D., Gandolfi, F., Palumbieri, M. D., Zaffagni, M., Genovesi, S., Lorenzoni, M., Celotti, M., Bertossio, E., Mazzero, G., Bertossi, A., Bisio, A., Berardinelli, F., Antoccia, A., Gaspari, M., Barbareschi, M., Fiorentino, M., … Lunardi, A. (2022). Intra‐epithelial non‐canonical Activin A signaling safeguards prostate progenitor quiescence. EMBO Reports, 23(5). Portico. https://doi.org/10.15252/embr.202154049
Publication Date
Biswas, A. K., Han, S., Tai, Y., Ma, W., Coker, C., Quinn, S. A., Shakri, A. R., Zhong, T. J., Scholze, H., Lagos, G. G., Mela, A., Manova-Todorova, K., de Stanchina, E., Ferrando, A. A., Mendelsohn, C., Canoll, P., Yu, H. A., Paik, P. K., Saqi, A., … Acharyya, S. (2022). Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse inEGFR-Mutant Lung Cancer. Cancer Discovery, 12(4), 1002–1021. https://doi.org/10.1158/2159-8290.cd-21-0910
Publication Date
Margolin, E. J., Wallace, B. K., Ha, A. S., Katz, M. J., Mikkilineni, N., Miles, C. H., Healy, K. A., Weiner, D. M., & Shah, O. (2022). Impact of an Acute Care Urology Service on Timelines and Quality of Care in the Management of Nephrolithiasis. Journal of Endourology, 36(3), 351–359. https://doi.org/10.1089/end.2021.0506
Publication Date
Bahmad, H. F., Demus, T., Moubarak, M. M., Daher, D., Alvarez Moreno, J. C., Polit, F., Lopez, O., Merhe, A., Abou-Kheir, W., Nieder, A. M., Poppiti, R., & Omarzai, Y. (2022). Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing. Medical Sciences, 10(1), 15. https://doi.org/10.3390/medsci10010015
Publication Date
Lopez-Bujanda, Z. A., Haffner, M. C., Chaimowitz, M. G., Chowdhury, N., Venturini, N. J., Patel, R. A., Obradovic, A., Hansen, C. S., Jacków, J., Maynard, J. P., Sfanos, K. S., Abate-Shen, C., Bieberich, C. J., Hurley, P. J., Selby, M. J., Korman, A. J., Christiano, A. M., De Marzo, A. M., & Drake, C. G. (2021). Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nature Cancer, 2(8), 803–818. https://doi.org/10.1038/s43018-021-00227-3
Publication Date
Perez, A., Nolte, A. C., Maurici, G., Small, A. C., Liem, S. S., Pereira, J. F., Polackwich, A. S., Yanes, R., & Shah, O. (2022). The “Tri-Glide” Technique: A Case Report on a Novel Intraoperative Approach for Removal of Retained and Encrusted Ureteral Stents. Case Reports in Urology, 2022, 1–4. https://doi.org/10.1155/2022/5708348
Publication Date
Reynolds, W. S., Suskind, A. M., Anger, J. T., Brucker, B. M., Cameron, A. P., Chung, D. E., Daignault‐Newton, S., Lane, G. I., Lucioni, A., Mourtzinos, A. P., Padmanabhan, P., Reyblat, P. X., Smith, A. L., Tenggardjaja, C. F., & Lee, U. J. (2022). Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi‐institutional collaboration from the SUFU research network. Neurourology and Urodynamics, 41(2), 662–671. Portico. https://doi.org/10.1002/nau.24871
Publication Date
Drake, C. G., Pachynski, R. K., Subudhi, S. K., McNeel, D. G., Antonarakis, E. S., Bauer, T. M., Lauer, P., Brockstedt, D., Patricia, D., Wade, M., Zudaire, E., Bandyopadhyay, N., Parasrampuria, D. A., Girgis, S., Mason, G. E., Knoblauch, R. E., Stone, N., Infante, J. R., Gottardis, M. M., & Fong, L. (2021). Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases, 25(2), 219–228. https://doi.org/10.1038/s41391-021-00402-8
Publication Date
Ho, P., Moran, G. W., Wang, V., Li, G., Virk, R. K., McKiernan, J. M., & Anderson, C. B. (2022). The effect of tumor grade heterogeneity on recurrence in non-muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations, 40(2), 60.e11-60.e16. https://doi.org/10.1016/j.urolonc.2021.07.003
Publication Date
Gorin, M. A., Patel, H. D., Rowe, S. P., Hahn, N. M., Hammers, H. J., Pons, A., Trock, B. J., Pierorazio, P. M., Nirschl, T. R., Salles, D. C., Stein, J. E., Lotan, T. L., Taube, J. M., Drake, C. G., & Allaf, M. E. (2022). Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma. European Urology Oncology, 5(1), 113–117. https://doi.org/10.1016/j.euo.2021.04.002
Publication Date
Hawley, J. E., Pan, S., Kandadi, H., Chaimowitz, M. G., Sheikh, N., & Drake, C. G. (2021). Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T. JNCI: Journal of the National Cancer Institute, 114(2), 314–317. https://doi.org/10.1093/jnci/djab145
Publication Date
Wallace, B. K., Miles, C. H., & Anderson, C. B. (2022). Effects of race and socioeconomic status on treatment for localized renal masses in New York City. Urologic Oncology: Seminars and Original Investigations, 40(2), 65.e19-65.e26. https://doi.org/10.1016/j.urolonc.2021.11.004
Publication Date
Kosber, R. L., Ha, A. S., Kurtzman, J. T., Blum, R., & Brandes, S. B. (2022). Hospital Ownership, Geographic Region, Patient Age, Comorbidities, and Insurance Status Appear to Influence Patient Selection Robot-Assisted Ureteral Reimplantation for Benign Disease: A Population-Based Analysis. Journal of Endourology, 36(2), 224–230. https://doi.org/10.1089/end.2021.0415
Publication Date
DAZA, J., OKHAWERE, K. E., IGE, O., ELBAKRY, A., SFAKIANOS, J. P., ABAZA, R., BHANDARI, A., EUN, D. D., HEMAL, A. K., PORTER, J., & BADANI, K. K. (2022). The role of RENAL score in predicting complications after robotic partial nephrectomy. Minerva Urology and Nephrology, 74(1). https://doi.org/10.23736/s2724-6051.20.03608-5
Publication Date
Lombardo, K. A., Obradovic, A., Singh, A. K., Liu, J. L., Joice, G., Kates, M., Bishai, W., McConkey, D., Chaux, A., Eich, M., Rezaei, M. K., Netto, G. J., Drake, C. G., Tran, P., Matoso, A., & Bivalacqua, T. J. (2021). BCG invokes superior STING‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer. The Journal of Pathology, 256(2), 223–234. Portico. https://doi.org/10.1002/path.5830
Publication Date
Margolis, E., Brown, G., Partin, A., Carter, B., McKiernan, J., Tutrone, R., Torkler, P., Fischer, C., Tadigotla, V., Noerholm, M., Donovan, M. J., & Skog, J. (2021). Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. Prostate Cancer and Prostatic Diseases, 25(2), 296–301. https://doi.org/10.1038/s41391-021-00456-8
Publication Date
Powles, T., Yuen, K. C., Gillessen, S., Kadel, E. E., Rathkopf, D., Matsubara, N., Drake, C. G., Fizazi, K., Piulats, J. M., Wysocki, P. J., Buchschacher, G. L., Alekseev, B., Mellado, B., Karaszewska, B., Doss, J. F., Rasuo, G., Datye, A., Mariathasan, S., Williams, P., & Sweeney, C. J. (2022). Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nature Medicine, 28(1), 144–153. https://doi.org/10.1038/s41591-021-01600-6
Publication Date
Kim, J. I., Zhu, D., Davila, J., Lee, J., Chubak, B. M., Melamed, M. L., & Abraham, N. (2021). Female Sexual Dysfunction as Measured by Low Sexual Frequency is Associated with Lower Socioeconomic Status: An Analysis of the National Health and Nutrition Examination Survey (NHANES), 2007-2016. The Journal of Sexual Medicine, 19(1), 90–97. https://doi.org/10.1016/j.jsxm.2021.09.014
Publication Date
Tate, T., Xiang, T., Wobker, S. E., Zhou, M., Chen, X., Kim, H., Batourina, E., Lin, C.-S., Kim, W. Y., Lu, C., Mckiernan, J. M., & Mendelsohn, C. L. (2021). Pparg signaling controls bladder cancer subtype and immune exclusion. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-26421-6
Publication Date
Weingart, S. N., Atoria, C. L., Pfister, D., Classen, D., Killen, A., Fortier, E., Epstein, A. S., Anderson, C., & Lipitz-Snyderman, A. (2018). Risk Factors for Adverse Events in Patients With Breast, Colorectal, and Lung Cancer. Journal of Patient Safety, 17(8), e701–e707. https://doi.org/10.1097/pts.0000000000000474
Publication Date
Schoenfeld, D., Zhu, D., Mohn, L., Di Vito, J., Agalliu, I., & Stern, J. M. (2021). The relationship between vascular calcifications and urolithiasis in a large, multiethnic patient population. Urolithiasis, 49(6), 533–541. https://doi.org/10.1007/s00240-021-01268-0
Publication Date
Margolin, E. J., Kurtzman, J. T., Gordon, R. J., Anderson, C. B., & Badalato, G. M. (2021). Efficacy of an Online Blended Learning Curriculum to Improve Medical Student Urologic Education. Medical Science Educator, 31(6), 2007–2015. https://doi.org/10.1007/s40670-021-01427-3
Publication Date
Vogl, U. M., Beer, T. M., Davis, I. D., Shore, N. D., Sweeney, C. J., Ost, P., Attard, G., Bossi, A., de Bono, J., Drake, C. G., Efstathiou, E., Fanti, S., Fizazi, K., Halabi, S., James, N., Mottet, N., Padhani, A. R., Roach, M., Rubin, M., … Gillessen, S. (2022). Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings. European Journal of Cancer, 160, 24–60. https://doi.org/10.1016/j.ejca.2021.09.036
Publication Date
Movassaghi, M., Wu, J., & Carpenter, C. P. (2021). Pediatric Penile Non-Involuting Congenital Hemangioma With an Associated Pyogenic Granuloma: Surgical Management of a Rare Vascular Anomaly. Urology, 158, 197–199. https://doi.org/10.1016/j.urology.2021.09.012
Publication Date